The historic treatment’s costs could top $1 million
An app to distinguish reality from hallucination, a probiotic for acne, and a lifesaving pump for heart-failure patients. These are but a few of brilliant ideas from promising healthcare start-ups...
Power source is flexible, transparent and runs on saltwater
Rosemarie Truman, CEO of the Center for Advancing Innovation, says a better system of governance for federally funded inventions could lead to many more good ones becoming commercialized...
Scientists hope to test experimental therapies on these “micro-brains”
The prospect of focusing the beams without destroying tissue might someday diagnose or even restore faulty brain circuits
The Food and Drug Administration, Sarepta and the case of the missing drug data
Bariatric surgery has been shown to relieve Type II diabetes. Scientists at Glyscend are developing a drug that could mimic the effect—but with no surgery required.
Scientists have integrated blood vessels into 3D-printed tissues, keeping them alive for up to 30 days.
Biofilms—3-D mats of bacteria—kill as many people as cancer does and fight off antibiotics. Now scientists are turning biofilms’ own weapons against them
European doctors use gene therapy to correct an inherited disease and replace 80 percent of Syrian refugee's epidermis
Eggs used to grow viruses for flu shots trigger changes that leave people vulnerable
The controversial approach aims to rejuvenate old tissue
Experts debate what amateur scientists could accomplish with the powerful DNA editing tool—and whether its ready availability is cause for concern
This tool could, in theory, fix genetic mistakes that lead to about 15,000 illnesses
A company called Kick wants to market to the masses a heart medication that would be used for reversing stage fright. Some medical professionals are getting agitated
Before anesthesia, surgeons battled patient agony during each procedure. But another foe awaited them next: postoperative infection
A compound that helps rodents and monkeys slim down could offer a promising approach for human therapies
Scientists have successfully edited the genes of human embryos. What does this mean for the future of genetic engineering?
The $215-million infusion will support immunotherapy work